Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors - PubMed (original) (raw)
Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors
P R Smith et al. J Virol. 1993 Jun.
Abstract
The most abundant polyadenylated viral transcripts in the Epstein-Barr virus (EBV)-associated tumor nasopharyngeal carcinoma are a family (apparent sizes, 4.8, 5.2, 6.2, and 7.0 kb) of highly spliced cytoplasmic RNAs expressed from the BamHI-I and -A regions of the viral genome in an antisense direction with respect to several viral lytic functions encoded within the same region and concerned with the lytic cycle of the virus. We have called these complementary-strand transcripts. They are also expressed in B cells, including Burkitt's lymphoma and EBV-immortalized marmoset cell lines, and tumors generated in cottontop tamarins in response to EBV infection, but at a lower level. The complete structure of the major 4.8-kb RNAs (seven or eight exons) was determined in this study; the larger, but related, transcripts appear to be produced by differential splicing. The transcriptional promoter for the major complementary-strand transcripts, located in BamHI-I, contains several well-characterized transcriptional control elements (E2A, SP1, and AP1) and is functionally active in both B lymphocytes and epithelial cells. It appears to be a bifunctional viral promoter, as it also contains the initiation codon for a gene (BILF2) that encodes a glycoprotein that is expressed off the other strand. Splicing events create a number of small AUG-initiated open reading frames, one of which has homology to functionally significant regions of the EBV-encoded nuclear antigen 2 and to E2 (in papillomavirus). The complex nature of these transcripts and their potential role in the virus association with malignancy are considered.
Similar articles
- The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB. Lear AL, et al. J Virol. 1992 Dec;66(12):7461-8. doi: 10.1128/JVI.66.12.7461-7468.1992. J Virol. 1992. PMID: 1331531 Free PMC article. - Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency.
Brooks LA, Lear AL, Young LS, Rickinson AB. Brooks LA, et al. J Virol. 1993 Jun;67(6):3182-90. doi: 10.1128/JVI.67.6.3182-3190.1993. J Virol. 1993. PMID: 8388496 Free PMC article. - EBV gene expression in an NPC-related tumour.
Hitt MM, Allday MJ, Hara T, Karran L, Jones MD, Busson P, Tursz T, Ernberg I, Griffin BE. Hitt MM, et al. EMBO J. 1989 Sep;8(9):2639-51. doi: 10.1002/j.1460-2075.1989.tb08404.x. EMBO J. 1989. PMID: 2479554 Free PMC article. - Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer.
Smith P. Smith P. Semin Cancer Biol. 2001 Dec;11(6):469-76. doi: 10.1006/scbi.2001.0414. Semin Cancer Biol. 2001. PMID: 11669609 Review. - The biology and chemistry of Epstein-Barr virus.
Kieff E, Dambaugh T, Heller M, King W, Cheung A, van Santen V, Hummel M, Beisel C, Fennewald S, Hennessy K, Heineman T. Kieff E, et al. J Infect Dis. 1982 Oct;146(4):506-17. doi: 10.1093/infdis/146.4.506. J Infect Dis. 1982. PMID: 6288806 Review.
Cited by
- Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective.
Escalante GM, Mutsvunguma LZ, Muniraju M, Rodriguez E, Ogembo JG. Escalante GM, et al. Front Immunol. 2022 Apr 14;13:867918. doi: 10.3389/fimmu.2022.867918. eCollection 2022. Front Immunol. 2022. PMID: 35493498 Free PMC article. - EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Fitzsimmons L, Kelly GL. Fitzsimmons L, et al. Viruses. 2017 Nov 13;9(11):339. doi: 10.3390/v9110339. Viruses. 2017. PMID: 29137176 Free PMC article. Review. - Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.
Hau PM, Deng W, Jia L, Yang J, Tsurumi T, Chiang AK, Huen MS, Tsao SW. Hau PM, et al. J Virol. 2015 Jan;89(1):652-68. doi: 10.1128/JVI.01437-14. Epub 2014 Oct 29. J Virol. 2015. PMID: 25355892 Free PMC article. - The role of miRNAs and EBV BARTs in NPC.
Marquitz AR, Raab-Traub N. Marquitz AR, et al. Semin Cancer Biol. 2012 Apr;22(2):166-72. doi: 10.1016/j.semcancer.2011.12.001. Epub 2011 Dec 10. Semin Cancer Biol. 2012. PMID: 22178394 Free PMC article. Review. - The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines.
Kim DN, Song YJ, Lee SK. Kim DN, et al. Exp Mol Med. 2011 Jul 30;43(7):401-10. doi: 10.3858/emm.2011.43.7.044. Exp Mol Med. 2011. PMID: 21628990 Free PMC article.
References
- J Virol. 1990 May;64(5):2126-34 - PubMed
- J Virol. 1992 May;66(5):2904-15 - PubMed
- Nature. 1989 Aug 3;340(6232):393-7 - PubMed
- EMBO J. 1989 Dec 20;8(13):4107-14 - PubMed
- J Virol. 1991 Nov;65(11):6252-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources